Maximilian J. Mair

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)

Matthias Preusser, Antonio Silvani, Émilie Le Rhun et al. · Neuro-Oncology · 2021 · 71 citations · Full text

Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations

Maximilian J. Mair, J.M. Berger, Anna S. Berghoff et al. · JAMA Oncology · 2021 · 68 citations · Full text

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

C. Geretsegger, Reinhold Fartaćek, C. Stuppaeck et al. · Psychopharmacology · 1995 · 58 citations

Geriatric Psychiatry, Psychiatry, Geriatrics +11

Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases

Rupert Bartsch, Anna S. Berghoff, Julia Furtner et al. · Neuro-Oncology · 2024 · 48 citations · Full text

LAG-3 expression in the inflammatory microenvironment of glioma

Maximilian J. Mair, Barbara Kiesel, Katharina Feldmann et al. · Journal of Neuro-Oncology · 2021 · 41 citations · Full text